This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2001 Mar 10;322(7286):603-5.

doi: 10.1136/bmj.322.7286.603.

Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility

M Lièvre¹, J Ménard, E Bruckert, J Cogneau, F Delahaye, P Giral, E Leitersdorf, G Luc, L Masana, P Moulin, P Passa, D Pouchain, G Siest

Affiliations

PMID: 11238162
PMCID: PMC1119794
DOI: 10.1136/bmj.322.7286.603

Review

Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility

M Lièvre et al. BMJ. 2001.

. 2001 Mar 10;322(7286):603-5.

doi: 10.1136/bmj.322.7286.603.

Authors

M Lièvre¹, J Ménard, E Bruckert, J Cogneau, F Delahaye, P Giral, E Leitersdorf, G Luc, L Masana, P Moulin, P Passa, D Pouchain, G Siest

Affiliation

¹ Clinical Pharmacology Unit, Faculté de Médecine Laënnec, BP 8071, 69376 Lyons Cedex 08, France.

PMID: 11238162
PMCID: PMC1119794
DOI: 10.1136/bmj.322.7286.603

No abstract available

PubMed Disclaimer

Comment in

Societal responsibilities of clinical trial sponsors. Lack of commercial pay off is not a legitimate reason for stopping a trial.
Evans S, Pocock S. Evans S, et al. BMJ. 2001 Mar 10;322(7286):569-70. doi: 10.1136/bmj.322.7286.569. BMJ. 2001. PMID: 11238141 Free PMC article. No abstract available.
Commentary: Early discontinuation violates Helsinki principles.
Boyd K. Boyd K. BMJ. 2001 Mar 10;322(7286):605-6. BMJ. 2001. PMID: 11269247 No abstract available.
Responsibilities of sponsors are limited in premature discontinuation of trials.
Ashcroft R. Ashcroft R. BMJ. 2001 Jul 7;323(7303):53. BMJ. 2001. PMID: 11464837 Free PMC article. No abstract available.

Similar articles

Responsibilities of sponsors are limited in premature discontinuation of trials.
Ashcroft R. Ashcroft R. BMJ. 2001 Jul 7;323(7303):53. BMJ. 2001. PMID: 11464837 Free PMC article. No abstract available.
Difficulties in negotiating research access.
Ames JC, Thompson S, Thurston MN. Ames JC, et al. Bull Med Ethics. 2001 Mar;(166):15-7. Bull Med Ethics. 2001. PMID: 11878334 No abstract available.
Toward a more comprehensive approach to protecting human subjects: the interface of data safety monitoring boards and institutional review boards in randomized clinical trials.
Gordon VM, Sugarman J, Kass N. Gordon VM, et al. IRB. 1998 Jan-Feb;20(1):1-5. IRB. 1998. PMID: 11655324 No abstract available.
Exploring the role and function of trial steering committees: results of an expert panel meeting.
Harman NL, Conroy EJ, Lewis SC, Murray G, Norrie J, Sydes MR, Lane JA, Altman DG, Baigent C, Bliss JM, Campbell MK, Elbourne D, Evans S, Sandercock P, Gamble C. Harman NL, et al. Trials. 2015 Dec 30;16:597. doi: 10.1186/s13063-015-1125-z. Trials. 2015. PMID: 26715378 Free PMC article.
Ethics of undisclosed payments to doctors recruiting patients in clinical trials.
Rao JN, Cassia LJ. Rao JN, et al. BMJ. 2002 Jul 6;325(7354):36-7. doi: 10.1136/bmj.325.7354.36. BMJ. 2002. PMID: 12098730 Free PMC article. Review. No abstract available.

See all similar articles

Cited by

The Influence of Industry Affiliation on Randomized Controlled Trials of Platelet-Rich Plasma for Knee Osteoarthritis.
Ta CN, Vasudevan R, Mitchell BC, Keller RA, Kent WT. Ta CN, et al. Am J Sports Med. 2023 Nov;51(13):3583-3590. doi: 10.1177/03635465221140917. Epub 2023 Jan 3. Am J Sports Med. 2023. PMID: 36594496 Free PMC article.
Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches.
Lawal TA, Todd JJ, Meilleur KG. Lawal TA, et al. Neurotherapeutics. 2018 Oct;15(4):885-899. doi: 10.1007/s13311-018-00677-1. Neurotherapeutics. 2018. PMID: 30406384 Free PMC article. Review.
Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study.
El Kababji S, Mitsakakis N, Jonker E, Beltran-Bless AA, Pond G, Vandermeer L, Radhakrishnan D, Mosquera L, Paterson A, Shepherd L, Chen B, Barlow W, Gralow J, Savard MF, Fesl C, Hlauschek D, Balic M, Rinnerthaler G, Greil R, Gnant M, Clemons M, El Emam K. El Kababji S, et al. J Med Internet Res. 2025 Mar 5;27:e66821. doi: 10.2196/66821. J Med Internet Res. 2025. PMID: 40053790 Free PMC article.
"One teabag is better than four": Participants response to the discontinuation of 2% PRO2000/5 microbicide gel in KwaZulu-Natal, South Africa.
Gafos M, Mzimela M, Ndlovu H, Mhlongo N, Hoogland Y, Mutemwa R. Gafos M, et al. PLoS One. 2011 Jan 21;6(1):e14577. doi: 10.1371/journal.pone.0014577. PLoS One. 2011. PMID: 21344002 Free PMC article. Clinical Trial.
17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial.
Combs CA, Garite TJ, Maurel K, Mallory K, Edwards RK, Lu G, Porreco R, Das A; Obstetrix Collaborative Research Network. Combs CA, et al. BMC Res Notes. 2011 Dec 29;4:568. doi: 10.1186/1756-0500-4-568. BMC Res Notes. 2011. PMID: 22206581 Free PMC article.

See all "Cited by" articles

References

1. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301–1307. - PubMed
1. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA. 1998;279:1615–1622. - PubMed
1. Fey R, Pearson N. Statins and coronary heart disease. Lancet. 1996;347:1389–1390. - PubMed
1. Muldoon MF, Criqui MH. The emerging role of statins in the prevention of coronary heart disease. BMJ. 1997;315:1554–1555. - PMC - PubMed
1. Ulrich S, Hingorani AD, Martin J, Vallance P. What is the optimal age for starting lipid lowering treatment? A mathematical model. BMJ. 2000;320:1134–1140. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information